Redwood City, Calif.-based CoAlign Innovations received FDA market clearance for the AccuLIF XL lateral expandable interbody fusion device line. The product line includes the AccuLIF TL for TLIF procedures and the AccuLIF PL for PLIF procedures. The systems are designed to be low profile with controlled expansion for precise anatomical reconstruction.
More Articles on Devices:
Smith & Nephew Allowed to Promote KFx Medical Rotator Cuff Repair Device
Australian Government Warns of LMT Surgical's Arthroplasty Device Safety
Stryker Awarded $85.5M DOD Contract for Hip, Knee Implants
FDA Clears CoAlign Innovations' AccuLIF Interbody Fusion Devices to Market
Spinal TechCopyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.